|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, February 14, 2019 ) The U.S. Conjugate Vaccine Market: The Conjugate vaccine is a type of vaccine that contains bacterial capsular polysaccharide, attached to a protein to enhance immunogenicity and protect against invasive diseases. The U.S. is one of the prominent markets for conjugate vaccines. Scheduled vaccination of conjugate vaccines has eradicated health disparities and consequently, the rate of incidence of diseases in the U.S. have been lower. Native Alaskan/American Indian and African-American children had much higher rates of invasive pneumococcal diseases than white children in the U.S. Vaccination has wiped out these health disparities, and the incidence of these diseases is now relatively low across all groups.
Download Free Report Sample (PDF) Here:https://www.researchreporthub.com/report/the-u-s-conjugate-vaccine-market/11306/#requestforsample
Market Segmentation:
o Based on disease indication, the market is segmented into pneumococcal, haemophilus influenza type b, diphtheria-tetanus-pertussis, meningococcal and others. The highest penetration among paediatrics is that of DTP vaccines.
o Based on end user, the market is segmented into pediatric and adult.
Key growth factors:
The U.S. is projected to be one of the most significant markets for conjugate vaccines during the forecast period, due to a rise in demand for pneumococcal, meningococcal vaccines, and other conjugate vaccines. Increased diagnosis and treatments would fuel the conjugate vaccines market. Recommended vaccines and dosages are updated on a regular basis to comply with prevalent serogroups of infectious agents. For example, the CDC has its own immunization schedule for U.S. citizens. This has increased the effectiveness of administered vaccines, which thereby boosts the demand for the product, leading to increase in market sales. Growing initiatives by HHS to reduce infectious diseases by increasing immunization rates and immunization recommendations will fuel the growth of the market. For instance, the Healthy People 2020 aims for immunization to prevent and treat infectious diseases.
Threats and key players:
o The U.S. conjugate vaccine market is expected to grow positively. But since it is a saturated market, the scope for significant growth is limited. In North America, the population above 65 years of age has decreased from the year 2014 to 2016. So, the demand for adult vaccines has also lowered. The overall penetration rates for the adult segment, is lower than that of the pediatric segment.
o Major conjugate vaccine providers operating in the market are GlaxoSmithKline, Pfizer Inc., Merck, Novartis, Sanofi Pasteur, etc.
Get Discount & Customization of this Report Here:https://www.researchreporthub.com/report/the-u-s-conjugate-vaccine-market/11306/
Table Of Content
Chapter 1: Executive summary
1.1 Market scope and segmentation
1.2 Key questions answered in this study
1.3 Executive summary - I
1.4 Executive summary - II
Chapter 2: Market overview
2.1. Market definitions
2.2. The U.S. market overview – by revenue
- The U.S. historical (2015-2017) market revenue (USD Bn)
- The U.S. forecasted (2018-2023) market revenue (USD Bn)
2.3. The U.S. market overview – by volume
- The U.S. historical (2015-2017) market volume (Million units)
- The U.S. forecasted (2018-2023) market volume (Million units)
2.4. The U.S. market drivers and challenges
2.4.1. The U.S. market drivers
2.4.2. The U.S. market challenges
2.5. The U.S. market trends
2.6. Value chain
Chapter 3: The U.S. major segment overview - by disease indication
3.1. Disease indication: Pneumococcal, Hib - by revenue, by volume, CAGR
- Overview - by disease indication
- Market share (2015, 2018 & 2023): Pneumococcal – The U.S. (USD Bn, Million units)
- Market share (2015, 2018 & 2023): Hib – The U.S. (USD Bn, Million units)
3.2. Disease indication: DTP, Meningococcal - by revenue, by volume, CAGR
- Overview - by disease indication
- Market share (2015, 2018 & 2023): DTP – The U.S. (USD Bn, Million units)
- Market share (2015, 2018 & 2023): Meningococcal – The U.S. (USD Bn, Million units)
Chapter 4: The U.S. major segment overview - by end user
4.1. End user: Pediatric, Adult - by revenue, by volume, CAGR
- Overview - by end user
- Market share (2015, 2018 & 2023): Paediatric – The U.S. (USD Bn, Million units)
- Market share (2015, 2018 & 2023): Adult – The U.S. (USD Bn, Million units)
Chapter 5: Competitive landscape
5.1. Company market share
- Top 5 companies
5.2. Company overview - GlaxoSmithKline
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
5.2(A) Executive profile – GlaxoSmithKline
5.3. Company overview – Pfizer Inc.
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
5.3(A) Executive profile - Pfizer Inc.
5.4. Company overview – Merck & Co.
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
5.4(A) Executive profile - Merck & Co.
5.5. Company overview – Novartis
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
.....
Get Complete TOC with Figures and Tables Here:https://www.researchreporthub.com/report/the-u-s-conjugate-vaccine-market/11306/#toc
Research Report Hub
Research Report Hub offers wide-ranging collection of market research reports under virtually every market verticals and sub-categories from different publishers across the globe. We offer reliable market intelligence reports and report customization services to better understand current and projected market scenarios. It also gives a clearer depiction of industries and facilitates to simply perceive competitor activity in the respective industry. Our services are also geared towards helping organizations procure market reports at the finest price.
About US
Research Report Hub
Sector 04, Plot 101, Sant Nagar,
Moshi PCNDTA, Pune, 412105
Maharashtra, India
Web:www.researchreporthub.com
Find us on:
https://www.facebook.com/reasearchreporthub/
https://twitter.com/hub_report
https://www.linkedin.com/company/research-report-hub/
Research Report Hub
Prakriti Mathur
+918448444687
sales@researchreporthub.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
